Increased expression of HSP90α has been reported in breast cancer, including SKBR3 cells [35], and cytotoxicity has also been reported for the use of HSP90α inhibitors in breast cancer cells, including SKBR3 [68-70]. The gene discussed is HSP90AA1; the disease is breast carcinoma.